Operating Income for Charles River (CRL)
According to Charles River's latest reported financial statements, the company's current operating income (TTM) is $428.82M USD. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingOperating IncomeSwitch metric
TTM (last 4 quarters)
$428.82M
YoY change
+123.4%
5Y CAGR
+3.3%
Peak year (2022)
$650.98M
Cumulative operating income
$5.78B
Operating Income history chart for Charles River (CRL) from 1998 to 2025
Operating Income history table for Charles River (CRL) from 1998 to 2025
| Fiscal year | Period ended | Reported | Operating Income | YoY |
|---|---|---|---|---|
| 2025 | $507.84M | +123.4% | ||
| 2024 | $227.35M | -63.2% | ||
| 2023 | $617.26M | -5.2% | ||
| 2022 | $650.98M | +10.4% | ||
| 2021 | $589.86M | +36.3% | ||
| 2020 | $432.73M | +23.2% | ||
| 2019 | $351.15M | +6.0% | ||
| 2018 | $331.38M | +15.0% | ||
| 2017 | $288.28M | +21.4% | ||
| 2016 | $237.55M | +15.1% | ||
| 2015 | $206.45M | +16.2% | ||
| 2014 | $177.67M | +17.4% | ||
| 2013 | $151.40M | -8.7% | ||
| 2012 | $165.76M | -4.9% | ||
| 2011 | $174.31M | -158.4% | ||
| 2010 | -$298.51M | -276.0% | ||
| 2009 | $169.61M | -137.7% | ||
| 2008 | -$449.76M | -298.0% | ||
| 2007 | $227.19M | +20.7% | ||
| 2006 | $188.17M | +1.9% | ||
| 2005 | $184.69M | +16.9% | ||
| 2004 | $157.99M | +14.0% | ||
| 2003 | $138.55M | +13.3% | ||
| 2002 | $122.27M | +35.4% | ||
| 2001 | $90.28M | +38.8% | ||
| 2000 | $65.06M | +51.4% | ||
| 1999 | $42.96M | +21.6% | ||
| 1998 | $35.33M | — |
Operating Income values are taken from Charles River's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Charles River (CRL) operating income totalled $507.84M – surged 123.4% year-over-year.
Over 2020–2025 (5 years), Charles River operating income expanded at a +3.3% compound annual rate, with the latest reading among the more recent periods of the dataset.
Charles River operating income peaked at $650.98M in 2022; the latest annual figure is $507.84M in 2025 (22.0% below peak).
The highest annual operating income of $650.98M was reported in 2022. The lowest in the available history was -$449.76M in 2008.
Within Healthcare, Charles River (CRL) ranks 9th among 8 peers we track. The peer median for operating income is $22.84B.
Charles River Operating Income by Year
Charles River Operating Income 2025: $507.84M
Charles River operating income in 2025 was $507.84M, surged 123.4% from 2024.
Charles River Operating Income 2024: $227.35M
Charles River operating income in 2024 was $227.35M, plunged 63.2% below 2023.
Charles River Operating Income 2023: $617.26M
Charles River operating income in 2023 was $617.26M, declined 5.2% below 2022.
Charles River Operating Income 2022: $650.98M
Charles River operating income in 2022 was $650.98M, grew 10.4% from 2021. This figure represents the highest annual value in the available history.
Charles River Operating Income 2021: $589.86M
Charles River operating income in 2021 was $589.86M.
See more financial history for Charles River (CRL).
Sector peers — Operating Income
Companies in the same sector as Charles River, ranked by their latest operating income.
| Company | Operating Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $127.66B | Healthcare |
| Eli Lilly and Company (LLY) | $29.70B | Healthcare |
| Merck & Co., Inc. (MRK) | $26.78B | Healthcare |
| Johnson & Johnson (JNJ) | $25.60B | Healthcare |
| AbbVie Inc. (ABBV) | $20.09B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $18.96B | Healthcare |
| AstraZeneca PLC (AZN) | $13.74B | Healthcare |
| Amgen Inc. (AMGN) | $10.68B | Healthcare |
Frequently asked questions
What is Charles River's operating income?
- Latest reported operating income for Charles River (CRL) is $428.82M (period ending December 27, 2025).
How has Charles River operating income changed year-over-year?
- Charles River (CRL) operating income changed +123.4% year-over-year on the latest annual filing.
What is the long-term growth rate of Charles River operating income?
- Charles River (CRL) operating income compound annual growth rate is +3.3% over the most recent 5 years available.
When did Charles River operating income hit its highest annual value?
- Charles River operating income reached its highest annual value of $650.98M in 2022.
What was Charles River operating income in 2024?
- Charles River (CRL) operating income in 2024 was $227.35M.
What was Charles River operating income in 2025?
- Charles River (CRL) operating income in 2025 was $507.84M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
CRL Overview
Company profile, financial tools, and key metrics
CRL Revenue Counter
Earns $127.33 every second. See per minute, hour, and day.
CRL Earnings Counter
Loses −$4.58 per second. See per minute, hour, and day.
CRL Economic Scale
Exceeds Curacao's GDP. Compare with world economies.
CRL What If Invested
What if you had invested $1,000? See historical returns from any date.
CRL How It Makes Money
Discover visual breakdown of $4.02B in revenue — where it comes from and where it goes.
CRL Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
CRL Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
CRL Daily Price Character
Balanced · 51.7% historical win rate (green days). Streaks & record days.
CRL Buybacks
3.60% TTM buyback yield. Shareholder yield & SBC comparison.